Thrombolysis in Myocardial Infarction (TIMI) phase II trial: Outcome comparison of a “conservative strategy” in community versus tertiary hospitals

This publication has 15 references indexed in Scilit:

• Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.
  BMJ, 1988
• TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1988
• Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator.
  Circulation, 1988
• A Randomized Trial of Intravenous Tissue Plasminogen Activator for Acute Myocardial Infarction with Subsequent Randomization to Elective Coronary Angioplasty
  New England Journal of Medicine, 1987
• Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.
  Circulation, 1987
• Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction
  Journal of the American College of Cardiology, 1986
• Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial.
  Circulation, 1986
• RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1985
• Effects of Intracoronary Streptokinase and Intracoronary Nitroglycerin Infusion on Coronary Angiographic Patterns and Mortality in Patients with Acute Myocardial Infarction
  New England Journal of Medicine, 1984
• Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions.
  Circulation, 1984